Product Description: G-36 is a cell-permeable nonsteroidal antagonist of the G protein-coupled estrogen receptor (GPER/GPR30), which selectively inhibits estrogen-mediated PI3K activation through GPER, rather than Erα. G-36 also inhibits estrogen-mediated calcium mobilization (IC50=112 nM). G-36 is promising for research in the field of cancer[1][2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C22H22BrNO2
References: [1]Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):358-66./[2]Yu X, et al. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries. PLoS One. 2018 Jan 23;13(1):e0191418.
CAS Number: 1392487-51-2
Molecular Weight: 412.32
Compound Purity: 99.66
Research Area: Cancer; Endocrinology
Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 80°C)
Target: Estrogen Receptor/ERR
English
Deutsch
